These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9205049

  • 1. Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors.
    Wang S, Souza RF, Kong D, Yin J, Smolinski KN, Zou TT, Frank T, Young J, Flanders KC, Sugimura H, Abraham JM, Meltzer SJ.
    Cancer Res; 1997 Jul 01; 57(13):2543-6. PubMed ID: 9205049
    [Abstract] [Full Text] [Related]

  • 2. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May 01; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 3. Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells.
    Souza RF, Wang S, Thakar M, Smolinski KN, Yin J, Zou TT, Kong D, Abraham JM, Toretsky JA, Meltzer SJ.
    Oncogene; 1999 Jul 15; 18(28):4063-8. PubMed ID: 10435587
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A, Tredget EE, Shen Q.
    J Cell Physiol; 1999 Jul 15; 180(1):61-70. PubMed ID: 10362018
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
    Rosenthal E, McCrory A, Talbert M, Young G, Murphy-Ullrich J, Gladson C.
    Mol Carcinog; 2004 Jun 15; 40(2):116-21. PubMed ID: 15170816
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 8. Gastric carcinomas with microsatellite instability: clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes.
    Iacopetta BJ, Soong R, House AK, Hamelin R.
    J Pathol; 1999 Mar 15; 187(4):428-32. PubMed ID: 10398102
    [Abstract] [Full Text] [Related]

  • 9. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.
    Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H, Shiiba K, Souza RF, Meltzer SJ, Horii A.
    Cancer Res; 1997 May 15; 57(10):1851-4. PubMed ID: 9157973
    [Abstract] [Full Text] [Related]

  • 10. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG.
    Cancer Res; 1999 Sep 01; 59(17):4314-9. PubMed ID: 10485478
    [Abstract] [Full Text] [Related]

  • 11. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 12. Microsatellite Analysis of the Insulin-Like Growth Factor II Receptor in Colorectal Carcinomas.
    Souza RF, Meltzer SJ.
    Methods Mol Med; 2001 Mar 15; 50():137-48. PubMed ID: 21318823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y, Zhong X, Uchida I, Koi M, Hemmi H.
    J Cell Physiol; 2001 Jun 15; 187(3):356-64. PubMed ID: 11319759
    [Abstract] [Full Text] [Related]

  • 15. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.
    Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, Barcellos-Hoff MH.
    Radiat Res; 2006 Dec 15; 166(6):839-48. PubMed ID: 17149983
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K, Yamamoto H, Taniguchi H, Adachi Y, Yoshida Y, Arimura Y, Endo T, Hinoda Y, Imai K.
    Clin Cancer Res; 2004 Dec 01; 10(23):7950-7. PubMed ID: 15585629
    [Abstract] [Full Text] [Related]

  • 18. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
    Carethers JM, Pham TT.
    In Vivo; 2000 Dec 01; 14(1):13-20. PubMed ID: 10757056
    [Abstract] [Full Text] [Related]

  • 19. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC, Matthews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK, Prime SS.
    J Pathol; 2001 Apr 01; 193(4):458-67. PubMed ID: 11276004
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
    Pedrozo HA, Schwartz Z, Mokeyev T, Ornoy A, Xin-Sheng W, Bonewald LF, Dean DD, Boyan BD.
    J Cell Biochem; 1999 Jan 01; 72(1):151-65. PubMed ID: 10025676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.